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1. Introduction 
       
      Indonesia is an archipelago country which has 13,466 islands, lying between Asia and 
Australia. More than 80% of Indonesia’s territory is covered with water, with its land area 
about 1,910,931.32 km2. The five major islands are Sumatra in the West, Java in the South, 
Kalimantan straddling the equator, Sulawesi, and Papua bordering Papua New Guinea. 
      According to the 2015 Population Census, the population of Indonesia was around 
252.4 million. This makes Indonesia the fourth most populous country in the world after the 
People’s Republic of China, India and the United Stated of America (USA).The large number 
of islands, population, and their dispersion over a wide area has given rise to diverse cultures, 
as well as six hundreds of ethnic groups and languages. However, the majority speak the 
national language, Bahasa Indonesia.   
      In the year of 2000, Clinical pharmacy has been implementing in Indonesia. According 
to SHPA, the definition of Clinical pharmacy practice is the practice of pharmacy as part of 
multidisciplinary healthcare team directed at achieving the quality use of medicines (QUM)1. 
This may include taking part in the medication management of individual patients, giving 
along of clinical knowledge and skills with the healthcare team, identifying and reducing risks 
associated with medicines use, taking part in the education of patients, carers, and other health 
professionals, and taking part in research. 
      Implementation of Clinical Pharmacy Practice in the Indonesian Health System 
requires support from Medication Management and Use System (MMUS). MMUS contains 
two systems that were integrated into one big system. The two systems are medication 
management system and medication use system. All of them integrate into one cycle including 
medicines selection, procurement, storage, distribution, prescribing, transcribing, 
preparation/compounding, dispensation, administration, documentation, monitoring and 
evaluation. 
      The objective of this study is to describe the Healthcare System in Indonesia, to 
elaborate the development of clinical pharmacy practice in Indonesia, and the role of higher 
education in preparing the human resources for supporting implementation of Clinical 
Pharmacy in Indonesia. 
 
2. Healthcare System 
     There are public and private sectors in Healthcare system in Indonesia, and starting in 
January 2014 when Indonesian Government launched Jaminan Kesehatan Nasional- JKN 
(National Health Coverage), which is managed by the Badan Penyelenggara Jaminan 
Sosial-BPJS (National Institution of Social Security). Coverage is expanded year after year; 
the goal is to complete coverage in 2019. In May 2014, the cover approx. is 50% of 
population. The JKN’s members and Premium Rates are divided two categories of members; 
those with incomes below the poverty line are premiumly paid by the government, and those 
who pay the premium. 
     The scheme of payment are as shown in Table 1: 
Table 1 Scheme of Premium Rates in JKN Indonesia 
Member Premium rates Monthly membership
 fee (IDR) 
Subsided members (below poverty line) NOMINAL  
(per member) 
19.225,- 
Civil servants/ army/ police/ retired      
seniors 
5%  
(per household ) 
2%  from employee  
3%  from employer 
Other workers – with monthly salary/ 
wage 
5%  
(per household) 
1%  from employee 
4%  from employer 
Workers – without monthly salary/wage  
OR independent members 
NOMINAL  
(per member) 
3 choices of benefits:  
1. 25.500,-  
2. 42.500,- 
3. 59.500,-   
 
The JKN method of payment for the JKN Health care providers are as follows: 
1. Primary health care providers. 
a. Capitation: advanced payment based on the number of registered members. 
b. Non-capitation: reimbursement based on the cost of healthcare that was provided. 
2. Secondary and tertiary health care providers. 
a. Ina-CBG’s (Case-based group): reimbursement based on the healthcare package 
for specific illnesses. 
 
3. The Development of Clinical Pharmacy 
 
3.1 Pharmacy Practice: Past (<2000s) 
      In 1995, there were 7,802 registered pharmacists: 43% in community pharmacy, 
10% in hospitals and 11% in industry. The Ratio is 1 pharmacist per 25,634 people. 
Practising pharmacists are registered with Ikatan Sarjana Farmasi Indonesia – ISFI 
(Pharmaceutical Society of Indonesia) that has no legal powers, has limited disciplinary 
powers, and is very much a loose federation of provincial branches. 
 
   3.2 Clinical Pharmacy Practice: Starting Point 
       The development of Clinical Pharmacy in Indonesia was started in the year 2000 
and published in The Pharmaceutical Journal Vol. 264 No. 7098 p. 817-819 May 27, 2000 
by C.K. Tan, PhD, M R Pharm S, and M. Aslam, PhD, F R Pharm S. In 1999 was set up a 
Centre for Medicines Information and Pharmaceutical Care (CMIPC), at Faculty of 
Pharmacy, Universitas Surabaya, as a result of the higher education link with British 
Council, Universita Surabaya and Nottingham University. The aims is to promote the 
effective, safe, rational and cost-effective use of medicines. 
          In 2003: clinical pharmacy included within the Faculty of Pharmacy Universitas 
    Surabaya curricula and in 2005 the first Magister in Clinical Pharmacy was established 
    in the Faculty of Pharmacy – Universitas Surabaya. There are some publications of  
    CMIPC for healthcare professionals and communities. Those are clinical pharmacy  
    textbooks, rational bulletins, medicament bulletins, iv admixture books, pregnancy 
  books, etc. 
 
    3.3 Clinical Pharmacy Practice: Present (2000s) 
            Indonesian Government Regulation No. 51 of 2009 regarding Pharmacy Practice  
       declares that Pharmacists are professional health personnels authorized to conduct   
       pharmaceutical practices that include:  
1. Production and quality control of pharmaceutical products.  
2. Safety assurance, procurement, storage and distribution of medications  
3. Supply of prescription medications.  
4. Provision of drug information services.  
5. Development of drugs, medical products and traditional medicines.  
Implementation of this regulation has consequences that practicing pharmacists 
should be nationally registered. The Indonesian government established Komite 
Farmasi Nasional – KFN (National Pharmacy Committee). The registration should be 
renewed every 5 years; Certificate of competency would be required for the 
registration. Ikatan Apoteker Indonesia (ISFI) was changed to be IAI (Indonesian 
Pharmacists Association) that has authority to publish Certificate of competency, renew 
the standards of competency for pharmacists (2011) which Clinical Pharmacy was 
included, develop a system for competency assessment with examination and portofolio 
(since 2014) and provide opportunity for Continuing Professional Development (CPD).  
     The Clinical Pharmacy Practice was supported by the Government with 
establishment of Standards of Pharmaceutical Care that supports Clinical Pharmacy 
Practice is as follows: 
 
1. Health Ministerial Regulation No. 30 Year 2014 
a) The Standards of Pharmaceutical Care at the Primary Health Centre,  
2. Health Ministerial Regulation No. 35 Year 2014  
a) The Standards of Pharmaceutical Care in Pharmacy, 
3. Health Ministerial Regulation No. 58 Year 2014  
a) The Standard of Pharmaceutical Care in Hospitals. 
 
             In 2015 there are 2,456 hospitals with 1,925 General Hospitals and 531 Special 
Hospitals. There are 1,321 Accredited Hospitals. 9,692 Primary Health Centres consist 
of 3,363 primary health centres with inpatient facilities and 6,329 primary health 
centres without inpatient facilities and 21,058 Pharmacies/apotek with 53,092 
registered pharmacists: 12,042 men and 41,050 women. 
With practice not fully conformed to the Standards, there were approximately 
46% of Government Hospitals and Primary Health Centres which complied with 
pharmaceutical Care Standard by 2014. 
 
 
  
    3.4 Clinical Pharmacy in Practice: Challenges 
      There are some challenges that face clinical pharmacy development in Indonesia 
include Pharmacists-physician-patient relations/interactions, pharmacist factors: 
knowledge and competence, dual employment, implementation of SOP, Physician 
factors: awareness and trust of pharmacists, Patient factors: awareness and trust of 
pharmacists, Organisational context of the pharmacy/hospital/other facilities, 
pharmacist time/availability, adequate staff resources, availibility of resources to 
provide services – e.g. counseling space, SOP, External environment and Relevance of 
pharmacy education to the needs of practice, organisation of roles between health 
professionals, remuneration, assistance (from IAI), policy (the Government). 
 
    3.5 Clinical Pharmacy in Practice: Future Recommendations 
      Future recommendation is followed by Integration of clinical pharmacy services 
into healthcare system under JKN; Establishment of appropriate remuneration; 
Improving professional environment and infrastructure, Syncronising education (and 
CPD/CPE) to practice needs, IT systems for dispensing and patient medication records, 
Adequate staff, Policy, professional standards, procedures and other materials; and 
Research – to support evidence based on practice. 
 
   4. The Role of Pharmacy Higher Education 
4.1 Pharmacy Education: Past (<2000s) 
      The development of pharmacy of higher education can be seen from how The 
Ministry of Education regulates pharmacy education. A qualified pharmacist is required 
to complete the pharmacy undergraduate course (S1) followed by a year pre-registration 
training (Apothecary). In 2000 there were 16 faculties of pharmacy with 8 of them were 
private and the pharmacy curriculum was heavily based towards pharmaceutics, 
pharmacognosy and laboratory work. 
 
   4.2 Pharmacy Education: Present (2000s) 
      The number of pharmacy colleges/faculties grows fascinating. There were 121 
colleges/faculties which offered undergraduate courses (S1) in 2015 from only 16 in 
2000. 78 colleges/faculties were accredited – 52 of them were private. 29 
colleges/faculties offered pre-registration course (Apothecary) in 2015.  
 
   4.2.1 Clinical Pharmacy Curriculum 
     In 2000, Asosiasi Perguruan Tinggi Farmasi Indonesia – APTFI (Indonesian 
Association of Higher Education of Pharmacy) was established. In 2003, Faculty of 
Pharmacy, University of Surabaya, included ‘clinical pharmacy’ in its Pharmacy 
undergraduate (S1) curricula. In 2008, APTFI developed a national pharmacy curricula 
which includes pharmacotherapy. At the current time, almost all pharmacy 
colleges/faculties have ‘clinical pharmacy’ subjects in their curriculum (S1).  
 
 
 
4.2.2 Indonesian National Qualification Framework (INQF). 
 
      Government Regulation No. 08 Year 2012 established the Indonesian National 
Qualifications Framework (KKNI/INQF) to be used in the preparation of the learning 
outcomes of graduates from each level of education nationwide. The aims are to make 
the level of competence and qualifications that can reconcile, equalize, and integrate 
the fields of education and job training as well as work experience in order to award 
the work, in accordance to the recognition of the competence of employment structure 
in various sectors.  
 
   4.2.3 Regulation 
Regulations that support Pharmacist Education: 
1. Law No. 20 Year 2003 on National Education System.  
2. Law No. 14 Year 2005 on Teachers and Lecturers. 
3. Law No. 36 Year 2009 on Health. 
4. Government Regulation No. 19 Year 2005 on National Education Standards. 
5. Government Regulation No. 51 Year 2009 on Pharmaceutical Works. 
6. Government Regulation No. 17 Year 2010 on Education Management and 
Implementation. 
7. Apothecary Education Standards issued by Indonesian Association of Pharmacy 
College (APTFI) and Work Practice Standards of Professional Pharmacists 
Indonesia issued in 2008. 
8. Apothecary Education Standard requires 2 semesters with at least 28 credits and 
40 credits maximum.  
 
5. Conclusion 
1. The clinical pharmacy practice in Indonesia is heading in the right track – supported 
by appropriate policy and standardised pharmacy education. 
 
2. More collaboration between policy makers, educational institutions, professional 
organisations and practitioners would be required to integrate pharmacists within 
healthcare team to ensure quality use of medicines and patient safety. 
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